Cart
sales@molnova.com
Hydroxyphenyllactic acid
CAS No. 306-23-0
Hydroxyphenyllactic acid( —— )
Catalog No. M29624 CAS No. 306-23-0
Hydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 5MG | 33 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 156 | In Stock |
|
| 100MG | 231 | In Stock |
|
| 200MG | 343 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxyphenyllactic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007.
-
DescriptionHydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007.
-
In VitroHydroxyphenyllactic acid (4-hydroxyphenyllactic acid) is an antifungal metabolite.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number306-23-0
-
Formula Weight182.175
-
Molecular FormulaC9H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (686.17 mM)
-
SMILESOC(Cc1ccc(O)cc1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Norgestimate metabol...
Norelgestromin is one of the active metabolites of norgestimate.It is a steroidal progestin used in contraceptive patches, where it is combined with the estrogen ethinyl estradiol.
-
17-DIMETHYLXANTHINE
Paraxanthine is a metabolite of caffeine (sc-202514) which functions as an adenosine receptor ligand and a PARP-1 inhibitor in pulmonary epithelial cells.
-
DL-3-AMINOISOBUTYRIC...
beta-aminoisobutyric acid is the product from the conversion of N-carbamyl-beta-aminoisobutyric acid by the enzyme Beta-ureidopropionase (EC 3.5.1.6) the last step in pyrimidine degradation. Beta-ureidopropionase deficiency is an inborn error of pyrimidine degradation associated with neurological abnormalities.
